epigallocatechin gallate has been researched along with harmine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bui, LC; Cariou, K; Dairou, J; Delabar, JM; Denhez, C; Dodd, RH; Gourdain, S; Janel, N; Rodrigues-Lima, F | 1 |
| Bharate, SB; Joshi, P; Kumar, A; Sharma, S; Vishwakarma, RA; Wani, A; Yadav, RR | 1 |
| Jarhad, DB; Jeong, LS; Kim, HR; Mashelkar, KK; Noh, M | 1 |
| Bian, J; Huang, J; Jiang, W; Li, Z; Tang, J; Xie, Y; Zhang, L | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Bartholome, A; Kampkötter, A; Klotz, LO; Sies, H; Tanner, S | 1 |
2 review(s) available for epigallocatechin gallate and harmine
| Article | Year |
|---|---|
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
Topics: Animals; Biological Products; Disease; Dyrk Kinases; Enzyme Activation; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases | 2018 |
A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in alternative splicing.
Topics: Alternative Splicing; Arginine; Humans; Nuclear Proteins; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Serine; Serine-Arginine Splicing Factors | 2022 |
4 other study(ies) available for epigallocatechin gallate and harmine
| Article | Year |
|---|---|
Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity.
Topics: Dyrk Kinases; Enzyme Inhibitors; Humans; Hydrogen Bonding; Indoles; KB Cells; Molecular Docking Simulation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines | 2013 |
Meridianin derivatives as potent Dyrk1A inhibitors and neuroprotective agents.
Topics: Cell Line, Tumor; Dyrk Kinases; Humans; Indole Alkaloids; Indoles; Models, Molecular; Neurons; Neuroprotective Agents; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyrimidines; Structure-Activity Relationship | 2015 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Epigallocatechin gallate-induced modulation of FoxO signaling in mammalian cells and C. elegans: FoxO stimulation is masked via PI3K/Akt activation by hydrogen peroxide formed in cell culture.
Topics: Animals; Animals, Genetically Modified; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Catechin; Cell Line; Dyrk Kinases; Forkhead Box Protein O1; Forkhead Transcription Factors; Gene Expression; Genes, Helminth; Harmine; Humans; Hydrogen Peroxide; Longevity; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Superoxide Dismutase; Transcription Factors | 2010 |